{
    "clinical_study": {
        "@rank": "92360", 
        "arm_group": {
            "arm_group_label": "Single", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "To evaluate the performance and safety of the Cardioband Adjustable Annuloplasty System for\n      repair of functional mitral regurgitation."
        }, 
        "brief_title": "Cardioband With Transfemoral Delivery System", 
        "condition": "Mitral Regurgitation", 
        "condition_browse": {
            "mesh_term": "Mitral Valve Insufficiency"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age > 18 years\n\n          -  Moderate to severe functional MR\n\n          -  Symptomatic Patients (NYHA ClassII-IV) despite optimal medical therapy , including\n             CRT if indicated.\n\n          -  LVEF \u2265 25%, LVEDD \u2264 65mm\n\n          -  Subject is high risk to undergo MV surgery (as assessed by a surgeon and a\n             cardiologist, at the site)\n\n          -  Transseptal catheterization and femoral vein access is determined to be  feasible\n\n          -  Subject is able and willing to give informed consent and follow protocol procedures\n\n        Exclusion Criteria:\n\n          -  Active bacterial endocarditis\n\n          -  Severe organic lesions with retracted chordae or congenital malformations with lack\n             of valvular tissue\n\n          -  Heavily calcified annulus or leaflets\n\n          -  Subjects in whom transesophageal echocardiography is contraindicated\n\n          -  Untreated clinically significant CAD requiring revascularization\n\n          -  CRT implant within 3 months prior to procedure\n\n          -  Any percutaneous coronary, carotid, endovascular intervention or carotid surgery\n             within 30 days or any coronary or endovascular surgery within 3 months\n\n          -  CVA or TIA within 6 months or severe carotid stenosis (>70% by Ultra sound)\n\n          -  Renal insufficiency requiring dialysis\n\n          -  Life expectancy of less than twelve months\n\n          -  Subject is participating in concomitant research studies of investigational products"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01841554", 
            "org_study_id": "CB1-2"
        }, 
        "intervention": {
            "arm_group_label": "Single", 
            "intervention_name": "Cardioband", 
            "intervention_type": "Device", 
            "other_name": "With Transfemoral delivery system"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Mitral Valve", 
            "Annuloplasty"
        ], 
        "lastchanged_date": "April 23, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Alec Vahanian, MD", 
                    "phone": "+33140256735/60"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "18 75877"
                    }, 
                    "name": "Bichat hospital"
                }, 
                "investigator": {
                    "last_name": "Alec Vahanian, Prof", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Karl-Heinz Kuck, Prof"
                }, 
                "contact_backup": {
                    "phone": "+49401818852305"
                }, 
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany", 
                        "zip": "5 20099"
                    }, 
                    "name": "Asklepios Klinik, St. Georg"
                }, 
                "investigator": {
                    "last_name": "Karl-Heinz Kuck, Prof", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Germany"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "Cardioband Adjustable Annuloplasty System For Transcatheter Repair of Mitral Valve Regurgitation", 
        "other_outcome": {
            "description": "Technical success rate of the implantation of the Cardioband\nTechnical feasibility of Cardioband adjustment\nCardioband ability to reduce mitral valve regurgitation (MR) Intra-procedure, at hospital discharge, and at 30 days.", 
            "measure": "Performance", 
            "safety_issue": "No", 
            "time_frame": "30 days"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France:ANSM", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Overall rate of Major Serious Adverse Events (SAEs)* and serious adverse device effects (SADE) until hospital discharge and at post-operative 30 days.\n* Death, myocardial infarction, cardiac tamponade, device related cardiac surgery, stroke", 
            "measure": "Safety \u2022 Overall rate of Major Serious Adverse Events (SAEs) and serious adverse safety", 
            "safety_issue": "Yes", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01841554"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "MR Severity at 6 and 12 months\nChange in 6 MWT  in 6 and 12 months\nChange in quality of life (MLHFQ) at 6 and 12 months", 
            "measure": "Performance", 
            "safety_issue": "No", 
            "time_frame": "up to 12 months"
        }, 
        "source": "Valtech Cardio Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Valtech Cardio Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}